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TITLE OF CASE  
Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss 
 
 
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
 
A young man presented with rapid, predominantly right-sided visual loss with a 
background of multifocal skin lesions. He showed panuveitis with bilateral 
multifocal retinal infiltrates and retinal vasculitis and visual acuity (VA) of Hand 
Movements. Multifocal brain lesions were identified. Biopsy of both skin and 
vitreous showed atypical lymphocytes, and immunohistochemistry confirmed T-cell 
lymphoma of gamma-delta subtype. Management with the CODOX-M/IVAC 
polychemotherapy regimen achieved rapid response including resolution of 
intraocular changes and substantial improvement of right VA to 6/7.5  but he 
relapsed before planned stem-cell transplantation. Salvage with the 
gemcitabine/dexamethasone/cisplatin regimen, although temporarily effective, 
was followed by further relapse including widespread brain involvement. 
 
BACKGROUND Why you think this case is important – why did you write it up? 
 
This is the first case of gamma-delta T-cell lymphoma to be reported with 
vitreoretinal involvement. The condition is aggressive and life-threatening. Rapid 
diagnosis and treatment may be life-saving and sight-saving, but long-term 
prognosis remains poor. 
 
CASE PRESENTATION Presenting features, medical/social/family history 
 
A 41 year-old Caucasian man presented with rapidly deteriorating vision in both eyes over 5 
days. The Right (R) eye saw hand movements only, the Left (L) 6/5 Snellen, deteriorating to 
6/38 within a few days. Ocular examination showed right panuveitis with severe vitritis, 
multifocal retinal infiltrates (particularly peri-arteriolar), and retinal arteriolitis (Figure 1). 
The left eye showed fewer, better-defined white retinal deposits (Figure 2). He was also 
noted to have multiple violaceous placoid skin lesions (Figure 3). The itchy but painless skin 
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lesions had been spreading and enlarging for several months and the largest, on the left 
buttock, was 5cmx2cm and apparently necrotising (Figure 4). He was otherwise physically 
well but had chronic anxiety treated with mirtazapine and propranolol. Differential diagnosis 
included Behçet’s disease, Sweet’s syndrome, pyoderma gangrenosum, disseminated viral, 
bacterial or fungal infection, or malignancy. He was commenced on empirical Valciclovir 1 
gm TDS, Doxycycline 100mg BD and Penicillin V 500 mg QID. 
 
INVESTIGATIONS If relevant 
 
Investigations revealed a normal full blood count, normal liver function, an elevated 
creatinine to 120 µmol/l), C-reactive protein (<1), angiotensin converting enzyme 43 IU/l, 
no autoantibodies, slightly raised IgA (3.22g/l) with no paraprotein bands, normal chest X-
ray, negative serology for syphilis, Aspergillus, Streptococcus, Borrelia, Herpes simplex 
(HSV) I + II, Human immunodeficiency virus I + II, Human T-lymphotrophic virus I + II and 
Rickettsia. Varicella-zoster (VZV) IgG (but not IgM) was detected and polymerase chain 
reaction (PCR) testing was negative for VZV, HSV I + II, Cytomegalovirus and Pneumocystis. 
 
Magnetic resonance imaging of head with angiography and contrast showed several distinct 
cerebral lesions involving the left cerebral peduncle and internal capsule, the splenium of the 
corpus callosum, ventricular trigones and left frontal pole, all suggesting neoplasia, with 
lymphoma being more likely than glioma on radiological grounds (Fig 5a,b). Whole-body 
computed tomography showed no lymph node enlargement, no bone lesions nor evidence of 
malignancy throughout the neck, thorax, abdomen or pelvis. 
 
Diagnostic total vitrectomy was performed, the sample demonstrating atypical lymphocytes 
with pleomorphic nuclei, some with prominent nucleoli (Fig 6). There were numerous cells 
undergoing apoptosis. Immunohistochemistry demonstrated that the atypical cells were 
positive for T-cell markers (CD2, CD3 (Fig 5), CD8>CD4 and CD79a) but CD5 was negative 
as were CD10, CD23 and CD30. There was focal positivity for CD56, and the Ki-67 growth 
fraction was very high at 95%. There were some CD68-positive macrophages in the 
background. T-cell receptor clonality was confirmed by PCR, with evidence of a monoclonal 
gamma-delta T-cell population.  
 
The patient also underwent incisional biopsy of the largest skin lesion, histology showing 
nested aggregates of atypical lymphocytes with prominent ‘tagging’ of these cells along the 
basal epidermis. In the deeper dermis, infiltrates were predominantly perivascular, without 
angio-invasion. Immunohistochemistry showed cells positive for CD2, CD3, CD45, CD56, 
TIA-1, granzyme B and S-100P; CD4, CD5, CD8 and CD20 were negative, and there was 
virtually complete loss of CD7. These features confirmed T-cell lymphoma of gamma-delta 
type, involving skin, eye and brain, a diagnosis confirmed at a supra-regional lymphoma 
multidisciplinary meeting.  
 
 
DIFFERENTIAL DIAGNOSIS If relevant 
 
The differential diagnosis of uveitis with skin lesions includes sarcoidosis, tuberculosis, 
syphilis, Behçet’s disease, Sweet syndrome, Lyme disease, herpetic disease, disseminated 
bacterial or fungal infection or rarely, neoplasia. However, apparently necrotising skin lesions 
with zonal retinitis strongly suggests neoplasia, fungal infection or rickettsiosis.  
 
TREATMENT If relevant  
 
The patient was commenced on the CODOX-M/IVAC polychemotherapy regimen (intravenous 
cyclophosphamise, doxorubicin, vincristine, high-dose methotrexate, alternating with 
ifosfamide, cytarabine and etoposide alongside intrathecal methotrexate and cytarabine), 
originally devised for Burkitt lymphoma but also utilised for high-grade non-Hodgkin 
lymphoma involving the CNS due to the incorporation of the CNS-penetrant agents 
methotrexate, cytarabine, ifosfamide and etoposide. Four cycles were administered to the 
patient over 3 months with no major complications. 
 
OUTCOME AND FOLLOW-UP   
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Retinal infiltration and intraocular involvement resolved rapidly on treatment and within 3 
cycles of chemotherapy, the patient’s vision had improved to virtually normal (R 6/7.5, L 6/6 
). The retinal vasculitis resolved entirely with widespread areas of residual pigment epithelial 
atrophy, fortuitously with restored macular function (Fig 7). The cutaneous plaques and 
necrotic buttock lesion resolved completely. Systemic re-staging via FDG-PET-CT and MRI 
brain revealed a complete metabolic and radiologic response. Unfortunately whilst awaiting 
consolidating syngeneic haemopoetic stem cell transplant (the patient has a twin brother), 
he underwent clinico-radiological progressive disease and salvage with the 
gemcitabine/dexamethasone/cisplatin regimen, although temporarily showing complete 
response, was followed by further intracerebral recurrence with widespread neurological 
deficit. Palliative care was organised. 
 
DISCUSSION Include a very brief review of similar published cases  
 
Intraocular lymphoma may be secondary to systemic lymphoma (in which cases lesions are 
usually discrete and choroidal) or may arise primarily within the eye (primary vitreoretinal 
lymphoma [PVRL], part of a presumed multicentric primary CNS and vitreoretinal 
malignancy). Intraocular lymphoma is increasing in incidence, but almost all cases are PVRL 
of large B-cell origin1. Primary vitreoretinal lymphoma of T-cell type is exceedingly rare with 
approximately 20 cases in total being reported2, and the latest case series of 7 patients 
required contributions from 6 specialist centres in 5 countries3. In contrast to systemic B-cell 
lymphomas involving the eyes that manifest usually in the choroid, T-cell malignancies tend 
to involve vitreous and retina, may also involve iris and optic nerve, and may simulate 
uveitis. A review of 29 reported cases of primary and secondary T-cell lymphomas involving 
the eye4 in 2008 showed a mean duration of symptoms of 3.7 months before presentation, 
with 45% having a previous history of T-cell lymphoma elsewhere (the mean delay between 
systemic and ocular involvement being 6 years). The predominant primary site was 
cutaneous, particularly of the mycosis fungoides type. Therapy choice and prognosis depend 
partly upon immunocytochemical classification but prognosis is often poor. 
 
Peripheral T-cell lymphomas constitute over 10% of non-Hodgkin lymphomas and are 
clinically and histologically diverse. Primary cutaneous gamma-delta T-cell lymphoma 
(PCGDTCL) is now separately listed in the World Health Organisation 2008 classification of 
lymphomas5 with two distinct anatomic subtypes: hepatosplenic and cutaneous. About 95% 
of normal T-cells express the αβ dimer form of T-cell receptor, whereas 5% express γδ. 
These cells are cytotoxic, have some regulatory function and normally lack both CD4 and 
CD86. Malignancies of the γδ cell are rare; only 2 of 62 cutaneous T-cell lymphomas bore 
this marker7. Mortality is higher in PCGDTCL than in other cutaneous T-cell lymphomas8. 
Involvement of the central nervous system is very rare, only 5 published cases being 
identified by a recent review9. Ocular adnexal involvement by PCGDTCL causing proptosis 
has been reported10,11 but intraocular involvement has been reported in only one patient with 
bilateral non-granulomatous anterior uveitis11. Involvement of the retina or ocular posterior 
segment has never previously been reported.  
 
 
 
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
 
Patients presenting with synchronous ocular and skin lesions should be investigated for 
systemic infection and malignancy 
 
Almost all lymphomas involving vitreous and retina are of B-cell origin. Intraocular T-cell 
lymphoma is extremely rare 
 
Early multidisciplinary input is key to rapid diagnosis and optimising patient outcomes 
 
The CODOX-M/IVAC polychemotherapy regimen is the current standard for high-grade non-
Hodgkin lymphomas involving CNS, but may not provide long-term resolution 
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FIGURE/VIDEO CAPTIONS figures should NOT be embedded in this document 
 
Figure 1 The right fundus at presentation showing severe vitritis with widespread multifocal 
retinal infiltrations of variable size, particularly perivascular. Visual acuity: Hand Movements 
 
Figure 2 The left fundus at presentation, with no vitritis but multifocal small well-defined 
retinal infiltrates 
 
Figure 3 One of several groups of itchy but painless violaceous skin lesions, this one on the 
thigh 
Page 4 of 12
Page 5 of 5 
 
Figure 4 The largest skin lesion, on the left buttock, measured 5cmx2cm and showed 
central crusting 
 
Figure 5 Horizontal (a) and coronal (b) T2-weighted MRI scans at presentation showing 
infiltration of left cerebral peduncle and internal capsule 
 
Figure 6 Vitrectomy sample showing atypical lymphocytes with pleomorphic nuclei, some 
with prominent nucleoli, and numerous apoptotic bodies. 
 
Figure 7 The right fundus after first-phase chemotherapy, three weeks after presentation, 
showing complete resolution of vasculitis, virtual elimination of retinal infiltration and 
widespread retinal pigment epithelial atrophy. Visual acuity: 6/7.5 
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Figure 1 The right fundus at presentation showing severe vitritis with widespread multifocal retinal 
infiltrations of variable size, particularly perivascular. Visual acuity: Hand Movements  
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Figure 2 The left fundus at presentation, with no vitritis but multifocal small well-defined retinal infiltrates  
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Figure 3 One of several groups of itchy but painless violaceous skin lesions, this one on the thigh  
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Figure 4 The largest skin lesion, on the left buttock, measured 5cmx2cm and showed central crusting  
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Figure 5 Horizontal (a) and coronal (b) T2-weighted MRI scans at presentation showing infiltration of left 
cerebral peduncle and internal capsule  
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Figure 6 Vitrectomy sample showing atypical lymphocytes with pleomorphic nuclei, some with prominent 
nucleoli, and numerous apoptotic bodies.  
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Figure 7 The right fundus after first-phase chemotherapy, three weeks after presentation, showing complete 
resolution of vasculitis, virtual elimination of retinal infiltration and widespread retinal pigment epithelial 
atrophy. Visual acuity: 6/7.5  
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